BioSig Technologies, Inc. (BSGM)
OTCMKTS: BSGM · Delayed Price · USD
0.350
0.00 (0.03%)
Jul 2, 2024, 3:58 PM EDT - Market closed
Company Description
BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms.
It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines.
The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy.
The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system.
BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
BioSig Technologies, Inc.
| Country | CT |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Anthony Amato |
Contact Details
Address: 55 Greens Farms Road Westport, Connecticut 06880 United States | |
| Phone | (203) 409-5444 |
| Website | biosig.com |
Stock Details
| Ticker Symbol | BSGM |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001530766 |
| CUSIP Number | 09073N201 |
| ISIN Number | US09073N3008 |
| Employer ID | 26-4333375 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Frederick D. Hrkac | President, Principal Executive Officer and Executive Vice President |
| Dr. Budimir S. Drakulic Ph.D. | Chief Scientist |
| Andrew Gornell Ballou | Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 27, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jun 26, 2024 | 8-K | Current Report |
| Jun 11, 2024 | 8-K | Current Report |
| Jun 10, 2024 | 8-K | Current Report |
| Jun 6, 2024 | D | Notice of Exempt Offering of Securities |
| Jun 6, 2024 | D | Notice of Exempt Offering of Securities |
| May 30, 2024 | 8-K | Current Report |
| May 30, 2024 | 424B5 | Filing |
| May 28, 2024 | 8-K | Current Report |
| May 21, 2024 | 8-K | Current Report |